Urogen Pharma Ltd (URGN)

Sales/Maturities of Investments

$1.73M

Quarterly · Period ending: · USD

URGN logo

URGN Sales/Maturities of Investments

Latest reported$1.73M
URGN Quarterly Sales/Maturities of Investments ($0.00 → $1.73M)
High-resolution chart · PNG

URGN sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
1,733,000
4,146,000
98,815,000
40,206,000
30,336,000
40,432,000
69,965,000
12,140,000
12,082,000
13,518,000
3,248,676
11,334,000
3,735,000
30,469,000
23,121,000
26,722,623
-88,000
13,621,000
9,631,000
20,793,000
10,984,000
15,311,000
49,638,000
13,893,000
38,111,000
22,499,000
38,490,000
14,100,000
0
0
-35,801,000
0
0
35,901,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.